Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.

ABSTRACT:

Background

Due to the COVID-19 pandemic, the Substance Abuse and Mental Health Services Administration (SAMHSA) has relaxed restrictions on methadone treatment in the United States. There is concern that the relaxation may increase fatal overdose rates. This study examines opioid treatment program (OTP) changes to methadone treatment during COVID-19 and changes in fatal methadone-involved overdose rates in Connecticut.

Methods

From July 8th to August 18th, 2020, we conducted a comprehensive state-wide survey of all eight OTPs that dispense methadone in Connecticut to examine programmatic changes during COVID-19. We also analyzed state-level data on confirmed accidental opioid-involved deaths to assess if relaxation of take-home dosing restrictions and in-person attendance re

SUBMITTER: Brothers S 

PROVIDER: S-EPMC9758251 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature